So many bipartisan drug pricing proposals, so little time.
Don’t be fooled by Big Pharma’s spin. There is no evidence the proposed Part B changes would impact patient access to drugs.
Patients like me cannot live with these prices, and we need lower price tags at the pharmacy counter now.
When you’re on a long list of medications, even smaller copays add up.
The US pays two to three times more than other developed nations for prescription drugs.
I shouldn’t have to pay $100 just to feel normal and find relief.
After Mainers speak out, slate of drug pricing reforms gains momentum.
The DOJ wants a jury trial for Mallinckrodt, the company at the heart of a 97,000 percent price spike for a gel mainly used to treat infant seizures.
I fear for the day that I’m told that I am no longer covered and I have to pay hundreds of dollars in order to avoid a life-ending stroke.
I find myself cancelling doctor's appointments because I realize that I can’t afford the copay to go because I already spent too much on my medications.
The Senate would give the state’s Health Policy Commission authority to demand information from drug companies that have failed to reach a negotiated price with the state secretary of health and human services.
After drug prices for MassHealth doubled in five years, Governor Charlie Baker and the state legislature are advancing budget proposals that would require drug companies to justify exorbitant prices and allow the state to negotiate drug costs on behalf of patients and taxpayers.
Colorado is the first state to place a price cap on out-of-control insulin prices.
I need these medications, and I’m sure I will continue to need others in the future. But these drug costs are simply too high.
Seniors should be able to afford their medication without having to sacrifice their dignity.
At the beginning of this year, I was stunned to find out that my Flexipen would cost $450 for a month’s supply.
Spunky Maryland’s new drug pricing affordability board will be enacted July 1. We expect more reforms to come from states this year.
The legislation sets a model for the nation to make prescription drugs more affordable.
Measure would outlaw deals that block generic prescription drugs.
We need legislation to stop deals for delay and patent thickets, AbbVie’s monopolistic bread and butter.